Please login to the form below

Not currently logged in
Email:
Password:

David Eatwell joins Porterhouse Insights

Eatwell joins the Porterhouse team from Cello Health Insight

Porterhouse Medical Group has appointed David Eatwell director in its research, insight and evidence consultancy Porterhouse Insights.

Eatwell (pictured left) joins Porterhouse from Cello Health Insight where he also worked as a director.

Prior to that, he worked within Consulting at McCann Health, where he led its Quantitative Centre of Excellence.

Earlier in his career, he worked at Novartis in its headquarters in Switzerland, within the company’s combinatorial lead synthesis chemistry research team.

Eatwell has a background in both qualitative and quantitative research methodologies, across a range of therapy areas and business needs.

“I am delighted that someone of David’s calibre is joining the Porterhouse Insights team,” said Fabrice Allum, managing director of Porterhouse Insights.

“David, with his innovative approaches and problem-solving mindset will help us deliver these to our clients and support their business decisions through these challenging times,” he added.

Article by
Lucy Parsons

20th January 2021

From: Marketing

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...